Aug 2026· International Urology and Nephrology· 0 citations· 34 references
Medicine
TL;DR
The future of nephrology will be defined not by a single disruptive innovation, but by the convergence of prevention, precision medicine, digital health, regenerative biology, and advanced kidney replacement technologies.
This paper summarizes the physiological changes associated with LKD surgery, resulting from reduced nephron mass, glomerular hyperfiltration, and blood pressure elevation, to the health risks associated with LKD surgery including chronic kidney disease, proteinuria, hypertension, preeclampsia, adverse psychology, and f...
Muhammad Tanzeel Abbasi, R. Prasad· World Journal of Nephrology· 0 citations
Abstract Artificial intelligence (AI) is reshaping kidney care by integrating electronic health records (EHRs), imaging, digital pathology, genomics, wearable biosensors, and longitudinal physiologic data into dynamic risk-prediction systems. Traditional nephrology risk stratification has relied on static variables and...
C. Thongprayoon, Noppawit Aiumtrakul, F. Pesce et al.· Risk Management and Healthca...· 0 citations
This review uses Tangshen formula, a classic traditional Chinese medicine (TCM) for DKD, to detail TCM's protective mechanisms and concisely summarizes the DKD-related preclinical progress of other TCMs over 5 years.
Jiang Li, Shuang Guo, Yufei Zhang et al.· Seminars in Nephrology· 0 citations
Genomic medicine has profoundly transformed Nephrology—a specialty uniquely positioned to take advantage of the mechanistic insights provided by genomics that can guide precision care. Genetic kidney diseases account for a substantial proportion of chronic kidney disease in both children and adults, and the integration...
Jacqueline Soraru, E. Biros, Aron Chakera et al.· Journal of Rare Diseases· 0 citations
Background and Objectives: Chronic kidney disease (CKD) affects roughly 788 million adults worldwide according to the Global Burden of Disease (GBD) 2023 estimate. Extracellular vesicles (EVs) are promising sources of biomarkers and therapeutic carriers, while artificial intelligence (AI) offers tools for high-dimensio...
Kumar Digvijay, H. Birn, Claudio Ronco· Medicina· 0 citations
Advances in mesenchymal stem cells, extracellular vesicles, CRISPR-based gene editing, and emerging precision medicine strategies including multi-omics profiling, machine learning-based patient stratification, and adaptive trial design are discussed.
Russell G. Saltzman, K. Asensi, Arnab Chakraborty et al.· Expert Review of Cardiovascu...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.